An illustration of a dual-capped mRNA and a capped circular RNA to augment cap-dependent translation initiation using branched topology. Chen et al. have developed a precise chemo-enzymatic method to ...

After layoffs this fall, Mythic Therapeutics is winding down, putting all its assets up for sale and terminating its only clinical trial. “The company is in the process of winding down and selling ...

SkyDeck and Bakar Labs to Highlight 24 Emerging Companies From Across Campus, Illustrating Berkeley’s ‘Open Bazaar’ Model for Scientific and Entrepreneurial Innovation BERKELEY, CA / ACCESS Newswire / ...

As 2025 comes to an end, it’s a good moment to take a look at what happened this year in biotech. Unlike years defined by one big breakthrough, 2025 felt more like a phase shift, where many trends ...

For this year’s ‘biotechs to watch’ selection, each Labiotech journalist picked five companies they believe will be worth following in 2026. Some earned their spot after clear momentum in 2025, while ...

After a year marked by dramatic ups and downs, William Blair analysts say 2026 could carry forward the industry’s current momentum—as long as strong clinical data continue to be rewarded and companies ...